当前位置: 首页 > 期刊 > 《第四军医大学学报》 > 2004年第4期
编号:10871505
良、恶性肾上腺肿瘤组织中端粒酶活性的鉴别意义
http://www.100md.com 《第四军医大学学报》 2004年第4期
肾上腺肿瘤,,端粒,末端转移酶;肾上腺肿瘤,0引言,1材料和方法,2结果,3讨论,【参考文献】
     Differential significance of telomerase activity in benign and malignant adrenal tumors

    FAN JinHai, SUN JunZhao, HE DaLin, HE Hui, XING JunPing, NAN XunYi

    Department of Urology, First Hospital, Xian Jiaotong University, Xian 710061, China

    【Abstract】 AIM: To determine whether tumors of the adrenal glands contain telomerase activity and whether telomerase activity can be used to differentiate benign adrenal tumors from malignant ones. METHODS: All tissue samples were obtained from 31 patients with adrenalectomy at the Department of Urology, the First Hospital, Xian Jiaotong University. All specimens were rapidly frozen in liquid nitrogen and stored at -80℃ until assay. Telomerase activity was determined by the telomeric repeat amplification protocol enzymelinked immunoassay (TRAPELISA). RESULTS: Of the 31 adrenal turmors, 6 (19.4%), in which 5 were malignant tumors, had telomerase activity. Of the telomerase positive samples, two were clinically known adrenocortical carcinoma, two were metastatic adrenal tumors (one from renal cell carcinoma, one from malignant neurinoma), one was malignant pheochromocytoma and one was nonfunctional cortical adrenoma. CONCLUSION: Benign adrenal tumors infrequently contain telomerase activity, whereas telomerase reactivation appears to be common in malignant tumors of the adrenal glands. The telomerase activity may facilitate the differentiation of benign from malignant adrenal tumors. ......

您现在查看是摘要页,全文长 7289 字符